ketendoКлиническая и экспериментальная тиреоидологияClinical and experimental thyroidology1995-54722310-3787Endocrinology Research Centre10.14341/ket12776ketendo-12776Research ArticleОбзорыReviewsТабакокурение, электронные сигареты и щитовидная железа: риски развития тиреоидной патологииTobacco smoking, e-cigarette and thyroid: what are the risks of thyroid disordershttps://orcid.org/0000-0002-9954-7641БеловаловаИ. М.BelovalovaI. M.

Беловалова Ирина Михайловна, к.м.н.

Москва

Irina M. Belovalova, MD, PhD

Moscow

belovalova.irina@endocrincentr.ruhttps://orcid.org/0000-0003-2396-2766ШугуроваЕ. С.ShugurovaE. S.

Шугурова Екатерина Станиславовна, эндокринолог

Москва

Ekaterina S. Shugurova, MD

Moscow

Shugurova.Ek@gmail.comhttps://orcid.org/0000-0002-6954-1126КорчагинаМ. О.KorchaginaM. O.

Корчагина Мария Олеговна, акушер-гинеколог 

117036, Москва, ул. Дм. Ульянова, д. 11 

Maria O. Korchagina, MD

11 Dm. Ulyanova street, 117036 Moscow

   

kmylavender@gmail.comhttps://orcid.org/0009-0007-8620-2437БорхоеваТ. Н.BorkhoevaT. N.

Борхоева Туяна Николаевна, эндокринолог

Москва

Tuyana N. Borkhoeva, MD

Moscow

2yaana0309@gmail.comhttps://orcid.org/0000-0003-3785-0335ШереметаМ. С.SheremetaM. S.

Шеремета Марина Сергеевна, к.м.н.

Москва

Marina S. Sheremeta, MD, PhD

Moscow

marina888@yandex.ruНациональный медицинский исследовательский центр эндокринологииРоссияEndocrinology Research CentreRussian Federation2023270220241921117Copyright © Беловалова И.М., Шугурова Е.С., Корчагина М.О., Борхоева Т.Н., Шеремета М.С., 20242024Беловалова И.М., Шугурова Е.С., Корчагина М.О., Борхоева Т.Н., Шеремета М.С.Belovalova I.M., Shugurova E.S., Korchagina M.O., Borkhoeva T.N., Sheremeta M.S.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.cet-endojournals.ru/jour/article/view/12776

Табакокурение — глобальная проблема здравоохранения уже многие годы. Особенно она усугубилась с момента массового производства табачных изделий. Давно не секрет, что табакокурение провоцирует различные заболевания, в том числе эндокринные, и способствует их прогрессированию. В настоящее время известно о роли генетической предрасположенности к развитию тиреоидной патологии и потенциальной роли различных средовых факторов в манифестации заболеваний щитовидной железы (ЩЖ). Наряду с потреблением йода, табакокурение — существенный фактор риска, влияющий на функциональное состояние и объем ЩЖ. С появлением электронных сигарет как альтернативы табачным изделиям возник закономерный вопрос: какое воздействие они оказывают на тиреоидный статус?

Настоящий литературный обзор обобщает современные представления о влиянии курения на ЩЖ, включая его взаимосвязь с изменением функции ЩЖ, развитием и прогрессированием заболеваний ЩЖ.

Tobacco smoking has been a global health problem for many years. It has especially worsened since the mass production of tobacco products. Tobacco smoking provokes various diseases, including endocrine diseases, and contributes to their progression. It is now known about the role of genetic predisposition to the development of thyroid pathology and the potential role of various environmental factors in the manifestation of thyroid diseases. Along with iodine intake, tobacco smoking is a significant risk factor affecting the functional status and volume of the thyroid gland. The introduction of electronic cigarettes as an alternative to tobacco products has raised a legitimate question: what effect do they have on thyroid status? The current literature review highlights current knowledge on the effects of smoking on the thyroid, including its relationship to changes in thyroid function and the development and progression of thyroid disorders.

никотинтиоцинатэкстракт сигаретного дыматабачная продукциятабакокурениеболезнь Грейвсаэндокринная офтальмопатияаутоиммунный тиреоидитдиффузный нетоксический зобрак щитовидной железыэлектронные системы доставки никотинаnicotinethiocyanatescigarette smoke extracttobacco productstobacco smokinggraves ophthalmopathygraves diseasegoiterthyroid neoplasmselectronic nicotine delivery systemsРабота выполнена в рамках государственного задания № 123021000041-6.ReferencesWho.int [Internet]. WORLD HEALTH ORGANIZATION: Health topics/Tobacco Available from: https://www.who.int/health-topics/tobacco#tab=tab_1Who.int [Internet]. WORLD HEALTH ORGANIZATION: Health topics/Tobacco Available from: https://www.who.int/health-topics/tobacco#tab=tab_1ПРОЕКТ Концепции осуществления государственной политики противодействия потреблению табака на 2017 - 2022 годы и дальнейшую перспективу. Доступно по: https://minzdrav.gov.ru/documents/9544. Ссылка активна на 29.01.24PROEKT Koncepcii osushhestvleniya gosudarstvennoj politiki protivodejstviya potrebleniyu tabaka na 2017 - 2022 gody` i dal`nejshuyu perspektivu (in Russ.)]. Доступно по: https://minzdrav.gov.ru/documents/9544. Ссылка активна на 29.01.24Mucha L, Stephenson J, Morandi N, et al. Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking. Gend Med. 2006;3(4):279-291. doi:10.1016/s1550-8579(06)80216-0Mucha L, Stephenson J, Morandi N, et al. Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking. Gend Med. 2006;3(4):279-291. doi:10.1016/s1550-8579(06)80216-0Global Cardiovascular Risk Consortium, Magnussen C, Ojeda FM, et al. Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality. N Engl J Med. 2023;389(14):1273-1285. doi:10.1056/NEJMoa2206916Global Cardiovascular Risk Consortium, Magnussen C, Ojeda FM, et al. Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality. N Engl J Med. 2023;389(14):1273-1285. doi:10.1056/NEJMoa2206916Pan B, Jin X, Jun L, et al. The relationship between smoking and stroke: A meta-analysis. Medicine (Baltimore). 2019;98(12):e14872. doi:10.1097/MD.0000000000014872Pan B, Jin X, Jun L, et al. The relationship between smoking and stroke: A meta-analysis. Medicine (Baltimore). 2019;98(12):e14872. doi:10.1097/MD.0000000000014872Adeloye D, Song P, Zhu Y, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447-458. doi:10.1016/S2213-2600(21)00511-7Adeloye D, Song P, Zhu Y, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447-458. doi:10.1016/S2213-2600(21)00511-7Gandini S, Botteri E, Iodice S, et al. Tobacco smoking and cancer: a meta-analysis. Int J Cancer. 2008;122(1):155-164. doi:10.1002/ijc.23033Gandini S, Botteri E, Iodice S, et al. Tobacco smoking and cancer: a meta-analysis. Int J Cancer. 2008;122(1):155-164. doi:10.1002/ijc.23033Carter BD, Abnet CC, Feskanich D, et al. Smoking and mortality--beyond established causes. N Engl J Med. 2015;372(7):631-640. doi:10.1056/NEJMsa1407211Carter BD, Abnet CC, Feskanich D, et al. Smoking and mortality--beyond established causes. N Engl J Med. 2015;372(7):631-640. doi:10.1056/NEJMsa1407211Chang JT, Anic GM, Rostron BL, et al. Cigarette Smoking Reduction and Health Risks: A Systematic Review and Meta-analysis. Nicotine Tob Res. 2021;23(4):635-642. doi:10.1093/ntr/ntaa156Chang JT, Anic GM, Rostron BL, et al. Cigarette Smoking Reduction and Health Risks: A Systematic Review and Meta-analysis. Nicotine Tob Res. 2021;23(4):635-642. doi:10.1093/ntr/ntaa156Paulis MG, Abbas MF, Abbas AH. Subchronic Effects of E-Cigarette and Conventional Tobacco Smoke Exposure on Pituitary and Thyroid Glands Functions: Comparative Experimental Study. Egypt J. Forensic Sci. Appli. Toxicol, Vol 15(2), December supp. 2015Paulis MG, Abbas MF, Abbas AH. Subchronic Effects of E-Cigarette and Conventional Tobacco Smoke Exposure on Pituitary and Thyroid Glands Functions: Comparative Experimental Study. Egypt J. Forensic Sci. Appli. Toxicol, Vol 15(2), December supp. 2015Kapoor D, Jones TH. Smoking and hormones in health and endocrine disorders. Eur J Endocrinol. 2005;152(4):491-499. doi:10.1530/eje.1.01867Kapoor D, Jones TH. Smoking and hormones in health and endocrine disorders. Eur J Endocrinol. 2005;152(4):491-499. doi:10.1530/eje.1.01867Babić Leko M, Gunjača I, Pleić N, Zemunik T. Environmental Factors Affecting Thyroid-Stimulating Hormone and Thyroid Hormone Levels. Int J Mol Sci. 2021;22(12):6521. Published 2021 Jun 17. doi:10.3390/ijms22126521Babić Leko M, Gunjača I, Pleić N, Zemunik T. Environmental Factors Affecting Thyroid-Stimulating Hormone and Thyroid Hormone Levels. Int J Mol Sci. 2021;22(12):6521. Published 2021 Jun 17. doi:10.3390/ijms22126521Kang J, Kong E, Choi J. Associations of Urinary Cotinine-Verified Active and Passive Smoking with Thyroid Function: Analysis of Population-Based Nationally Representative Data. Thyroid. 2018;28(5):583-592. doi:10.1089/thy.2017.0567Kang J, Kong E, Choi J. Associations of Urinary Cotinine-Verified Active and Passive Smoking with Thyroid Function: Analysis of Population-Based Nationally Representative Data. Thyroid. 2018;28(5):583-592. doi:10.1089/thy.2017.0567Asvold BO, Bjøro T, Nilsen TI, Vatten LJ. Tobacco smoking and thyroid function: a population-based study. Arch Intern Med. 2007;167(13):1428-1432. doi:10.1001/archinte.167.13.1428Asvold BO, Bjøro T, Nilsen TI, Vatten LJ. Tobacco smoking and thyroid function: a population-based study. Arch Intern Med. 2007;167(13):1428-1432. doi:10.1001/archinte.167.13.1428Utiger RD. Effects of smoking on thyroid function. Eur J Endocrinol. 1998;138(4):368-369. doi:10.1530/eje.0.1380368Utiger RD. Effects of smoking on thyroid function. Eur J Endocrinol. 1998;138(4):368-369. doi:10.1530/eje.0.1380368Sawicka-Gutaj N, Gutaj P, Sowiński J, et al. Influence of cigarette smoking on thyroid gland--an update. Endokrynol Pol. 2014;65(1):54-62. doi:10.5603/EP.2014.0008.Sawicka-Gutaj N, Gutaj P, Sowiński J, et al. Influence of cigarette smoking on thyroid gland--an update. Endokrynol Pol. 2014;65(1):54-62. doi:10.5603/EP.2014.0008.Hegedüs L, Karstrup S, Veiergang D, et al. High frequency of goitre in cigarette smokers. Clin Endocrinol (Oxf). 1985;22(3):287-292. doi:10.1111/j.1365-2265.1985.tb03242.xHegedüs L, Karstrup S, Veiergang D, et al. High frequency of goitre in cigarette smokers. Clin Endocrinol (Oxf). 1985;22(3):287-292. doi:10.1111/j.1365-2265.1985.tb03242.xPetersen K, Lindstedt G, Lundberg PA, et al. Thyroid disease in middle-aged and elderly Swedish women: thyroid-related hormones, thyroid dysfunction and goitre in relation to age and smoking. J Intern Med. 1991;229(5):407-413. doi:10.1111/j.1365-2796.1991.tb00367.xPetersen K, Lindstedt G, Lundberg PA, et al. Thyroid disease in middle-aged and elderly Swedish women: thyroid-related hormones, thyroid dysfunction and goitre in relation to age and smoking. J Intern Med. 1991;229(5):407-413. doi:10.1111/j.1365-2796.1991.tb00367.xKim J, Song H, Lee J, et al. Smoking and passive smoking increases mortality through mediation effect of cadmium exposure in the United States. Sci Rep. 2023 Mar 8;13(1):3878. doi: 10.1038/s41598-023-30988-z.Kim J, Song H, Lee J, et al. Smoking and passive smoking increases mortality through mediation effect of cadmium exposure in the United States. Sci Rep. 2023 Mar 8;13(1):3878. doi: 10.1038/s41598-023-30988-z.Picciotto MR, Kenny PJ. Mechanisms of Nicotine Addiction. Cold Spring Harb Perspect Med. 2021;11(5):a039610. doi:10.1101/cshperspect.a039610Picciotto MR, Kenny PJ. Mechanisms of Nicotine Addiction. Cold Spring Harb Perspect Med. 2021;11(5):a039610. doi:10.1101/cshperspect.a039610Tweed JO, Hsia SH, Lutfy K, Friedman TC. The endocrine effects of nicotine and cigarette smoke. Trends Endocrinol Metab. 2012;23(7):334-342. doi:10.1016/j.tem.2012.03.006Tweed JO, Hsia SH, Lutfy K, Friedman TC. The endocrine effects of nicotine and cigarette smoke. Trends Endocrinol Metab. 2012;23(7):334-342. doi:10.1016/j.tem.2012.03.006Vestergaard P. Smoking and thyroid disorders--a meta-analysis. Eur J Endocrinol. 2002;146(2):153-161. doi:10.1530/eje.0.1460153Vestergaard P. Smoking and thyroid disorders--a meta-analysis. Eur J Endocrinol. 2002;146(2):153-161. doi:10.1530/eje.0.1460153Colzani R, Fang SL, Alex S, et al. The effect of nicotine on thyroid function in rats. Metabolism. 1998;47(2):154-157. doi:10.1016/s0026-0495(98)90212-8Colzani R, Fang SL, Alex S, et al. The effect of nicotine on thyroid function in rats. Metabolism. 1998;47(2):154-157. doi:10.1016/s0026-0495(98)90212-8Alzoubi KH, Aleisa AM, Gerges NZ, et al. Nicotine reverses adult-onset hypothyroidism-induced impairment of learning and memory: Behavioral and electrophysiological studies. J Neurosci Res. 2006;84(5):944-953. doi:10.1002/jnr.21014Alzoubi KH, Aleisa AM, Gerges NZ, et al. Nicotine reverses adult-onset hypothyroidism-induced impairment of learning and memory: Behavioral and electrophysiological studies. J Neurosci Res. 2006;84(5):944-953. doi:10.1002/jnr.21014Rehan M, Zargar UR, Sheikh IA, et al. Potential Disruption of Systemic Hormone Transport by Tobacco Alkaloids Using Computational Approaches. Toxics. 2022;10(12):727. Published 2022 Nov 26. doi:10.3390/toxics10120727Rehan M, Zargar UR, Sheikh IA, et al. Potential Disruption of Systemic Hormone Transport by Tobacco Alkaloids Using Computational Approaches. Toxics. 2022;10(12):727. Published 2022 Nov 26. doi:10.3390/toxics10120727Fukayama H, Nasu M, Murakami S, Sugawara M. Examination of antithyroid effects of smoking products in cultured thyroid follicles: only thiocyanate is a potent antithyroid agent. Acta Endocrinol (Copenh). 1992;127(6):520-525. doi:10.1530/acta.0.1270520Fukayama H, Nasu M, Murakami S, Sugawara M. Examination of antithyroid effects of smoking products in cultured thyroid follicles: only thiocyanate is a potent antithyroid agent. Acta Endocrinol (Copenh). 1992;127(6):520-525. doi:10.1530/acta.0.1270520Serrano-Nascimento C, Nunes MT. Perchlorate, nitrate, and thiocyanate: Environmental relevant NIS-inhibitors pollutants and their impact on thyroid function and human health. Front Endocrinol (Lausanne). 2022;13:995503. Published 2022 Oct 21. doi:10.3389/fendo.2022.995503Serrano-Nascimento C, Nunes MT. Perchlorate, nitrate, and thiocyanate: Environmental relevant NIS-inhibitors pollutants and their impact on thyroid function and human health. Front Endocrinol (Lausanne). 2022;13:995503. Published 2022 Oct 21. doi:10.3389/fendo.2022.995503Tonacchera M, Pinchera A, Dimida A, et al. Relative potencies and additivity of perchlorate, thiocyanate, nitrate, and iodide on the inhibition of radioactive iodide uptake by the human sodium iodide symporter. Thyroid (2004) 14(12):1012–9. doi: 10.1089/thy.2004.14.1012Tonacchera M, Pinchera A, Dimida A, et al. Relative potencies and additivity of perchlorate, thiocyanate, nitrate, and iodide on the inhibition of radioactive iodide uptake by the human sodium iodide symporter. Thyroid (2004) 14(12):1012–9. doi: 10.1089/thy.2004.14.1012Hayashi M, Futawaka K, Matsushita M, et al. Cigarette Smoke Extract Disrupts Transcriptional Activities Mediated by Thyroid Hormones and Its Receptors. Biol Pharm Bull. 2018;41(3):383-393. doi: 10.1248/bpb.b17-00735.Hayashi M, Futawaka K, Matsushita M, et al. Cigarette Smoke Extract Disrupts Transcriptional Activities Mediated by Thyroid Hormones and Its Receptors. Biol Pharm Bull. 2018;41(3):383-393. doi: 10.1248/bpb.b17-00735.Gruppen EG, Kootstra-Ros J, Kobold AM, et al. Cigarette smoking is associated with higher thyroid hormone and lower TSH levels: the PREVEND study. Endocrine. 2020 Mar;67(3):613-622. doi: 10.1007/s12020-019-02125-2.Gruppen EG, Kootstra-Ros J, Kobold AM, et al. Cigarette smoking is associated with higher thyroid hormone and lower TSH levels: the PREVEND study. Endocrine. 2020 Mar;67(3):613-622. doi: 10.1007/s12020-019-02125-2.Jorde R, Sundsfjord J. Serum TSH levels in smokers and non-smokers. The 5th Tromsø study. Exp Clin Endocrinol Diabetes. 2006;114(7):343-347. doi:10.1055/s-2006-924264Jorde R, Sundsfjord J. Serum TSH levels in smokers and non-smokers. The 5th Tromsø study. Exp Clin Endocrinol Diabetes. 2006;114(7):343-347. doi:10.1055/s-2006-924264Bartalena L, Bogazzi F, Tanda ML, et al. Cigarette smoking and the thyroid. Eur J Endocrinol. 1995;133(5):507-512. doi:10.1530/eje.0.1330507Bartalena L, Bogazzi F, Tanda ML, et al. Cigarette smoking and the thyroid. Eur J Endocrinol. 1995;133(5):507-512. doi:10.1530/eje.0.1330507Fukayama H, Nasu M, Murakami S, et al. Examination of antithyroid effects of smoking products in cultured thyroid follicles: only thiocyanate is a potent antithyroid agent. Acta Endocrinol (Copenh). 1992;127(6):520-525. doi:10.1530/acta.0.1270520Fukayama H, Nasu M, Murakami S, et al. Examination of antithyroid effects of smoking products in cultured thyroid follicles: only thiocyanate is a potent antithyroid agent. Acta Endocrinol (Copenh). 1992;127(6):520-525. doi:10.1530/acta.0.1270520Prummel MF, Wiersinga WM. Smoking and risk of Graves' disease. JAMA 1993:269:479-82. doi:10.1001/jama.269.4.479Prummel MF, Wiersinga WM. Smoking and risk of Graves' disease. JAMA 1993:269:479-82. doi:10.1001/jama.269.4.479Ericsson UB, Lindgärde F. Effects of cigarette smoking on thyroid function and the prevalence of goitre, thyrotoxicosis and autoimmune thyroiditis. J Intern Med. 1991;229(1):67-71. doi:10.1111/j.1365-2796.1991.tb00308.xEricsson UB, Lindgärde F. Effects of cigarette smoking on thyroid function and the prevalence of goitre, thyrotoxicosis and autoimmune thyroiditis. J Intern Med. 1991;229(1):67-71. doi:10.1111/j.1365-2796.1991.tb00308.xWiersinga WM. Smoking and thyroid. Clin Endocrinol (Oxf). 2013 Aug;79(2):145-51. doi: 10.1111/cen.12222.Wiersinga WM. Smoking and thyroid. Clin Endocrinol (Oxf). 2013 Aug;79(2):145-51. doi: 10.1111/cen.12222.Antonelli A, Ferrari SM, Ragusa F, et al. Graves' disease: Epidemiology, genetic and environmental risk factors and viruses. Best Pract Res Clin Endocrinol Metab. 2020;34(1):101387. doi:10.1016/j.beem.2020.101387Antonelli A, Ferrari SM, Ragusa F, et al. Graves' disease: Epidemiology, genetic and environmental risk factors and viruses. Best Pract Res Clin Endocrinol Metab. 2020;34(1):101387. doi:10.1016/j.beem.2020.101387Kurzynska A, Przybylik-Mazurek E, Węgrzynowicz K, et al. Wpływ wybranych czynników biologicznych oraz środowiskowych na przebieg i wystąpienie powikłań u pacjentów z chorobą Gravesa-Basedowa [Influence of selected endogenous and environmental factors on the course and complications of Grave's disease]. Przegl Lek. 2014;71(12):672-6. Polish. PMID: 25951694.Kurzynska A, Przybylik-Mazurek E, Węgrzynowicz K, et al. Wpływ wybranych czynników biologicznych oraz środowiskowych na przebieg i wystąpienie powikłań u pacjentów z chorobą Gravesa-Basedowa [Influence of selected endogenous and environmental factors on the course and complications of Grave's disease]. Przegl Lek. 2014;71(12):672-6. Polish. PMID: 25951694.Shine B, Fells P, Edwards OM, et al. Association between Graves' ophthalmopathy and smoking. Lancet. 1990;335(8700):1261-1263. doi:10.1016/0140-6736(90)91315-2Shine B, Fells P, Edwards OM, et al. Association between Graves' ophthalmopathy and smoking. Lancet. 1990;335(8700):1261-1263. doi:10.1016/0140-6736(90)91315-2Träisk F, Tallstedt L, Abraham-Nordling M, et al. Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131. J Clin Endocrinol Metab. 2009;94(10):3700-3707. doi:10.1210/jc.2009-0747Träisk F, Tallstedt L, Abraham-Nordling M, et al. Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131. J Clin Endocrinol Metab. 2009;94(10):3700-3707. doi:10.1210/jc.2009-0747Bartalena L, Piantanida E. Cigarette smoking: number one enemy for Graves ophthalmopathy. Pol Arch Med Wewn. 2016;126(10):725-726. doi:10.20452/pamw.3592Bartalena L, Piantanida E. Cigarette smoking: number one enemy for Graves ophthalmopathy. Pol Arch Med Wewn. 2016;126(10):725-726. doi:10.20452/pamw.3592Pfeilschifter J, Ziegler R. Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption. Clin Endocrinol (Oxf). 1996;45(4):477-481. doi:10.1046/j.1365-2265.1996.8220832.xPfeilschifter J, Ziegler R. Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption. Clin Endocrinol (Oxf). 1996;45(4):477-481. doi:10.1046/j.1365-2265.1996.8220832.xChoi W, Li Y, Ji YS, et al. Oxidative stress markers in tears of patients with Graves' orbitopathy and their correlation with clinical activity score. BMC Ophthalmol. 2018;18(1):303. Published 2018 Nov 21. doi:10.1186/s12886-018-0969-xChoi W, Li Y, Ji YS, et al. Oxidative stress markers in tears of patients with Graves' orbitopathy and their correlation with clinical activity score. BMC Ophthalmol. 2018;18(1):303. Published 2018 Nov 21. doi:10.1186/s12886-018-0969-xCawood TJ, Moriarty P, O'Farrelly C, et al. Smoking and thyroid-associated ophthalmopathy: A novel explanation of the biological link. J Clin Endocrinol Metab. 2007 Jan;92(1):59-64. doi: 10.1210/jc.2006-1824.Cawood TJ, Moriarty P, O'Farrelly C, et al. Smoking and thyroid-associated ophthalmopathy: A novel explanation of the biological link. J Clin Endocrinol Metab. 2007 Jan;92(1):59-64. doi: 10.1210/jc.2006-1824.Francus T, Manzo G, Canki M, et al. Two peaks of interleukin 1 expression in human leukocytes cultured with tobacco glycoprotein. J Exp Med. 1989;170(1):327-332. doi:10.1084/jem.170.1.327Francus T, Manzo G, Canki M, et al. Two peaks of interleukin 1 expression in human leukocytes cultured with tobacco glycoprotein. J Exp Med. 1989;170(1):327-332. doi:10.1084/jem.170.1.327Hofbauer LC, Mühlberg T, König A, et al. Soluble interleukin-1 receptor antagonist serum levels in smokers and nonsmokers with Graves' ophthalmopathy undergoing orbital radiotherapy. J Clin Endocrinol Metab. 1997;82(7):2244-2247. doi:10.1210/jcem.82.7.4068Hofbauer LC, Mühlberg T, König A, et al. Soluble interleukin-1 receptor antagonist serum levels in smokers and nonsmokers with Graves' ophthalmopathy undergoing orbital radiotherapy. J Clin Endocrinol Metab. 1997;82(7):2244-2247. doi:10.1210/jcem.82.7.4068Quadbeck B, Roggenbuck U, Janssen OE, et al. Impact of smoking on the course of Graves’ disease after withdrawal of antithyroid drugs. Exp Clin Endocrinol Diabetes. 2006; 114: 406–411. https://doi.org/10.1055/s-2006-924065Quadbeck B, Roggenbuck U, Janssen OE, et al. Impact of smoking on the course of Graves’ disease after withdrawal of antithyroid drugs. Exp Clin Endocrinol Diabetes. 2006; 114: 406–411. https://doi.org/10.1055/s-2006-924065Plazinska MT, Sawicka-Gutaj N, Czarnywojtek A, et al. Radioiodine therapy and Graves' disease - Myths and reality. PLoS One. 2020;15(1):e0226495. Published 2020 Jan 13. doi:10.1371/journal.pone.0226495Plazinska MT, Sawicka-Gutaj N, Czarnywojtek A, et al. Radioiodine therapy and Graves' disease - Myths and reality. PLoS One. 2020;15(1):e0226495. Published 2020 Jan 13. doi:10.1371/journal.pone.0226495Czarnywojtek A, Komar-Rychlicka K, Zgorzalewicz-Stachowiak M, et al. Efficacy and safety of radioiodine therapy for mild Graves ophthalmopathy depending on cigarette consumption: a 6 month follow up. Pol Arch Med Wewn. 2016;126(10):746-753. doi:10.20452/pamw.3505Czarnywojtek A, Komar-Rychlicka K, Zgorzalewicz-Stachowiak M, et al. Efficacy and safety of radioiodine therapy for mild Graves ophthalmopathy depending on cigarette consumption: a 6 month follow up. Pol Arch Med Wewn. 2016;126(10):746-753. doi:10.20452/pamw.3505Caulley L, Johnson-Obaseki S, Luo L, et al. Risk factors for postoperative complications in total thyroidectomy: A retrospective, risk-adjusted analysis from the National Surgical Quality Improvement Program. Medicine (Baltimore). 2017 Feb;96(5):e5752. doi: 10.1097/MD.0000000000005752.Caulley L, Johnson-Obaseki S, Luo L, et al. Risk factors for postoperative complications in total thyroidectomy: A retrospective, risk-adjusted analysis from the National Surgical Quality Improvement Program. Medicine (Baltimore). 2017 Feb;96(5):e5752. doi: 10.1097/MD.0000000000005752.Belin RM, Astor BC, Powe NR, et al. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2004;89(12):6077-6086. doi:10.1210/jc.2004-0431Belin RM, Astor BC, Powe NR, et al. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2004;89(12):6077-6086. doi:10.1210/jc.2004-0431Kim SJ, Kim MJ, Yoon SG, et al. Impact of smoking on thyroid gland: dose-related effect of urinary cotinine levels on thyroid function and thyroid autoimmunity. Sci Rep. 2019;9(1):4213. Published 2019 Mar 12. doi:10.1038/s41598-019-40708-1Kim SJ, Kim MJ, Yoon SG, et al. Impact of smoking on thyroid gland: dose-related effect of urinary cotinine levels on thyroid function and thyroid autoimmunity. Sci Rep. 2019;9(1):4213. Published 2019 Mar 12. doi:10.1038/s41598-019-40708-1Park S, Kim WG, Jeon MJ, et al. Serum thyroid-stimulating hormone levels and smoking status: Data from the Korean National Health and Nutrition Examination Survey VI. Clin Endocrinol (Oxf). 2018;88(6):969-976. doi:10.1111/cen.13606Park S, Kim WG, Jeon MJ, et al. Serum thyroid-stimulating hormone levels and smoking status: Data from the Korean National Health and Nutrition Examination Survey VI. Clin Endocrinol (Oxf). 2018;88(6):969-976. doi:10.1111/cen.13606Knudsen N, Bülow I, Laurberg P, Ovesen L, Perrild H, Jørgensen T. Association of tobacco smoking with goiter in a low-iodine-intake area. Arch Intern Med. 2002;162(4):439-443. doi:10.1001/archinte.162.4.439Knudsen N, Bülow I, Laurberg P, Ovesen L, Perrild H, Jørgensen T. Association of tobacco smoking with goiter in a low-iodine-intake area. Arch Intern Med. 2002;162(4):439-443. doi:10.1001/archinte.162.4.439Волкова А.Р., Красильникова Е.И., Беркович О.А. и др. Функциональное состояние щитовидной железы, курение и кардиоваскулярный риск у больных ишемической болезнью сердца. Ученые записки СПбГМУ им. акад. И.П. Павлова. 2010; 17 (2): 17–21.Volkova A.R., Krasilnikova E.I., Berkovich O.A. et al. Thyroid gland function, smoking, and cardiovascular risk in heart ischemic disease patients. The Scientific Notes of the Pavlov University. 2010; 17 (2): 17–21 (in Russ).]Lee JH, Chai YJ, Yi KH. Effect of Cigarette Smoking on Thyroid Cancer: Meta-Analysis. Endocrinol Metab (Seoul). 2021. Jun;36(3):590-598. doi: 10.3803/EnM.2021.954.Lee JH, Chai YJ, Yi KH. Effect of Cigarette Smoking on Thyroid Cancer: Meta-Analysis. Endocrinol Metab (Seoul). 2021. Jun;36(3):590-598. doi: 10.3803/EnM.2021.954.Zhang L, Fang C, Liu L, et al. A case-control study of urinary levels of iodine, perchlorate and thiocyanate and risk of papillary thyroid cancer. Environ Int. 2018;120:388-393. doi:10.1016/j.envint.2018.08.024Zhang L, Fang C, Liu L, et al. A case-control study of urinary levels of iodine, perchlorate and thiocyanate and risk of papillary thyroid cancer. Environ Int. 2018;120:388-393. doi:10.1016/j.envint.2018.08.024Mack WJ, Preston-Martin S, Dal Maso L, et al. A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes Control. 2003;14(8):773-785. doi:10.1023/a:1026349702909Mack WJ, Preston-Martin S, Dal Maso L, et al. A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes Control. 2003;14(8):773-785. doi:10.1023/a:1026349702909Negri E, Ron E, Franceschi S, et al. Risk factors for medullary thyroid carcinoma: a pooled analysis. Cancer Causes Control. 2002;13(4):365-372. doi:10.1023/a:1015263718760Negri E, Ron E, Franceschi S, et al. Risk factors for medullary thyroid carcinoma: a pooled analysis. Cancer Causes Control. 2002;13(4):365-372. doi:10.1023/a:1015263718760Kabat GC, Kim MY, Wactawski-Wende J, Rohan TE. Smoking and alcohol consumption in relation to risk of thyroid cancer in postmenopausal women. Cancer Epidemiol. 2012;36(4):335-340. doi:10.1016/j.canep.2012.03.013Kabat GC, Kim MY, Wactawski-Wende J, Rohan TE. Smoking and alcohol consumption in relation to risk of thyroid cancer in postmenopausal women. Cancer Epidemiol. 2012;36(4):335-340. doi:10.1016/j.canep.2012.03.013Kitahara CM, Linet MS, Beane Freeman LE, et al. Cigarette smoking, alcohol intake, and thyroid cancer risk: a pooled analysis of five prospective studies in the United States. Cancer Causes Control. 2012;23(10):1615-1624. doi:10.1007/s10552-012-0039-2Kitahara CM, Linet MS, Beane Freeman LE, et al. Cigarette smoking, alcohol intake, and thyroid cancer risk: a pooled analysis of five prospective studies in the United States. Cancer Causes Control. 2012;23(10):1615-1624. doi:10.1007/s10552-012-0039-2Barbeau AM, Burda J, Siegel M. Perceived efficacy of e-cigarettes versus nicotine replacement therapy among successful e-cigarette users: a qualitative approach. Addict Sci Clin Pract. 2013 Mar 5;8(1):5. doi: 10.1186/1940-0640-8-5.Barbeau AM, Burda J, Siegel M. Perceived efficacy of e-cigarettes versus nicotine replacement therapy among successful e-cigarette users: a qualitative approach. Addict Sci Clin Pract. 2013 Mar 5;8(1):5. doi: 10.1186/1940-0640-8-5.Rom O, Pecorelli A, Valacchi G, et al. Are E-cigarettes a safe and good alternative to cigarette smoking? Ann N Y Acad Sci. 2015 Mar;1340:65-74. doi: 10.1111/nyas.12609.Rom O, Pecorelli A, Valacchi G, et al. Are E-cigarettes a safe and good alternative to cigarette smoking? Ann N Y Acad Sci. 2015 Mar;1340:65-74. doi: 10.1111/nyas.12609.Grana R, Benowitz N, Glantz SA. E-cigarettes: a scientific review. Circulation. 2014 May 13;129(19):1972-86. doi: 10.1161/CIRCULATIONAHA.114.007667. PMID: 24821826; PMCID: PMC4018182.Grana R, Benowitz N, Glantz SA. E-cigarettes: a scientific review. Circulation. 2014 May 13;129(19):1972-86. doi: 10.1161/CIRCULATIONAHA.114.007667. PMID: 24821826; PMCID: PMC4018182.Valentine GW, Hefner K, Jatlow PI, et al. Impact of E-cigarettes on Smoking and Related Outcomes in Veteran Smokers With Psychiatric Comorbidity. J Dual Diagn. 2018;14(1):2-13. doi:10.1080/15504263.2017.1384877Valentine GW, Hefner K, Jatlow PI, et al. Impact of E-cigarettes on Smoking and Related Outcomes in Veteran Smokers With Psychiatric Comorbidity. J Dual Diagn. 2018;14(1):2-13. doi:10.1080/15504263.2017.1384877Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23(2):133-139. doi:10.1136/tobaccocontrol-2012-050859Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23(2):133-139. doi:10.1136/tobaccocontrol-2012-050859Who.int [Internet]. WORLD HEALTH ORGANIZATION: News/Urgent action needed to protect children and prevent the uptake of e-cigarettes. Available from: https://www.who.int/news/item/14-12-2023-urgent-action-needed-to-protect-children-and-prevent-the-uptake-of-e-cigarettesWho.int [Internet]. WORLD HEALTH ORGANIZATION: News/Urgent action needed to protect children and prevent the uptake of e-cigarettes. Available from: https://www.who.int/news/item/14-12-2023-urgent-action-needed-to-protect-children-and-prevent-the-uptake-of-e-cigarettesArastoo S, Haptonstall KP, Choroomi Y, et al. Acute and chronic sympathomimetic effects of e-cigarette and tobacco cigarette smoking: role of nicotine and non-nicotine constituents. Am J Physiol Heart Circ Physiol. 2020;319(2):H262-H270. doi:10.1152/ajpheart.00192.2020Arastoo S, Haptonstall KP, Choroomi Y, et al. Acute and chronic sympathomimetic effects of e-cigarette and tobacco cigarette smoking: role of nicotine and non-nicotine constituents. Am J Physiol Heart Circ Physiol. 2020;319(2):H262-H270. doi:10.1152/ajpheart.00192.2020Андреева О.П., Терехов А.А. ЭЛЕКТРОННЫЕ СИГАРЕТЫ: АЛЬТЕРНАТИВА КУРЕНИЮ ИЛИ ВРЕД // Наука и образование. 2022. №2Andreeva O.P., Terekhov A.A. ELECTRONIC CIGARETTES: ALTERNATIVE TO SMOKING OR HARM // Nauka i Obrazovanie. 2022. №2 (in Russ.)]

The authors declare that there are no conflicts of interest present.